These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2208115

  • 1. Increased sensitivity to Vinca alkaloids in cells overexpressing calmodulin by gene transfection.
    Ido M, Lagacé L, Chafouleas JG.
    Cancer Res; 1990 Oct 15; 50(20):6554-8. PubMed ID: 2208115
    [Abstract] [Full Text] [Related]

  • 2. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT, Cirtain MC, Look AT, Ashmun RA.
    Cancer Res; 1986 Feb 15; 46(2):778-84. PubMed ID: 3455678
    [Abstract] [Full Text] [Related]

  • 3. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
    Gan PP, Kavallaris M.
    Cancer Res; 2008 Dec 01; 68(23):9817-24. PubMed ID: 19047161
    [Abstract] [Full Text] [Related]

  • 4. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T.
    Gan To Kagaku Ryoho; 1984 Mar 01; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [Abstract] [Full Text] [Related]

  • 5. The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo.
    Liu J, Qi S, Zhu H, Zhang J, Li Z, Wang T.
    Chin Med J (Engl); 2002 May 01; 115(5):759-62. PubMed ID: 12133551
    [Abstract] [Full Text] [Related]

  • 6. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
    Haber M, Norris MD, Kavallaris M, Bell DR, Davey RA, White L, Stewart BW.
    Cancer Res; 1989 Oct 01; 49(19):5281-7. PubMed ID: 2569932
    [Abstract] [Full Text] [Related]

  • 7. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
    Inaba M, Nagashima K.
    Jpn J Cancer Res; 1986 Feb 01; 77(2):197-204. PubMed ID: 3082832
    [Abstract] [Full Text] [Related]

  • 8. Increased mdr gene expression and decreased drug accumulation in multidrug-resistant human melanoma cells.
    Lemontt JF, Azzaria M, Gros P.
    Cancer Res; 1988 Nov 15; 48(22):6348-53. PubMed ID: 3180053
    [Abstract] [Full Text] [Related]

  • 9. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
    Makarov AA, Tsvetkov PO, Villard C, Esquieu D, Pourroy B, Fahy J, Braguer D, Peyrot V, Lafitte D.
    Biochemistry; 2007 Dec 25; 46(51):14899-906. PubMed ID: 18052208
    [Abstract] [Full Text] [Related]

  • 10. The effects of altered cellular calmodulin expression on the growth and viability of C6 glioblastoma cells.
    Prostko CR, Zhang C, Hait WN.
    Oncol Res; 1997 Dec 25; 9(1):13-7. PubMed ID: 9112256
    [Abstract] [Full Text] [Related]

  • 11. Altered synthesis of the 26-kDa heat stress protein family and thermotolerance in cell lines with elevated levels of calcium-binding proteins.
    Evans DP, Simonette RA, Rasmussen CD, Means AR, Tomasovic SP.
    J Cell Physiol; 1990 Mar 25; 142(3):615-27. PubMed ID: 2312618
    [Abstract] [Full Text] [Related]

  • 12. Enhanced efflux of [3H]vinblastine from Chinese hamster ovary cells transfected with a full-length complementary DNA clone for the mdr1 gene.
    Hammond JR, Johnstone RM, Gros P.
    Cancer Res; 1989 Jul 15; 49(14):3867-71. PubMed ID: 2736530
    [Abstract] [Full Text] [Related]

  • 13. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
    Pereira E, Tarasiuk J, Garnier-Suillerot A.
    Chem Biol Interact; 1998 Jul 03; 114(1-2):61-76. PubMed ID: 9744556
    [Abstract] [Full Text] [Related]

  • 14. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics.
    Tsuruo T.
    Cancer Treat Rep; 1983 Oct 03; 67(10):889-94. PubMed ID: 6354436
    [Abstract] [Full Text] [Related]

  • 15. Selective and reversible effects of vinca alkaloids on Trypanosoma cruzi epimastigote forms: blockage of cytokinesis without inhibition of the organelle duplication.
    Grellier P, Sinou V, Garreau-de Loubresse N, Bylèn E, Boulard Y, Schrével J.
    Cell Motil Cytoskeleton; 1999 Oct 03; 42(1):36-47. PubMed ID: 9915583
    [Abstract] [Full Text] [Related]

  • 16. Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas.
    Houghton JA, Williams LG, Torrance PM, Houghton PJ.
    Cancer Res; 1984 Feb 03; 44(2):582-90. PubMed ID: 6692363
    [Abstract] [Full Text] [Related]

  • 17. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
    Beck WT, Cirtain MC, Lefko JL.
    Mol Pharmacol; 1983 Nov 03; 24(3):485-92. PubMed ID: 6579344
    [Abstract] [Full Text] [Related]

  • 18. Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected for resistance to vinca alkaloids.
    Sirotnak FM, Yang CH, Mines LS, Oribé E, Biedler JL.
    J Cell Physiol; 1986 Feb 03; 126(2):266-74. PubMed ID: 3944208
    [Abstract] [Full Text] [Related]

  • 19. Calmodulin, activated cyclic nucleotide phosphodiesterase, microtubules, and vinca alkaloids.
    Watanabe K, West WL.
    Fed Proc; 1982 May 03; 41(7):2292-9. PubMed ID: 6122611
    [Abstract] [Full Text] [Related]

  • 20. Riboflavin-mediated photosensitization of Vinca alkaloids distorts drug sensitivity assays.
    Granzow C, Kopun M, Kröber T.
    Cancer Res; 1995 Nov 01; 55(21):4837-43. PubMed ID: 7585517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.